Tracking heart and lung health without wires or electrodes could be a game-changer for home care, assisted living or for patients who resist traditional wearables.
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial.
This summer, Cornell Tech welcomed the first-ever cohort of the City University of New York (CUNY) Honors Connect program, which culminated in a showcase of student-led research on July 31.
Cornell researchers have discovered a new cell signaling pathway involved in ovulation, a potential target for future research on infertility, contraception and ovarian disease.
Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus will use a $5.1 million grant from the NIH to launch the Autism Replication, Validation, and Reproducibility Center, which aims to improve the reliability of autism research.
Using high-pressure X-ray scattering at CHESS, researchers uncovered key structural differences between conventional and centromeric nucleosomes, revealing how our DNA remains organized and resilient under extreme stress.
A new study revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing mystery of how the disease spreads and identifying a promising target for therapy.